-transparent.png){kind=logo}
We examined the in vivo effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in primates (cynomolgus monkeys) treated with subcutaneous doses of rhG-CSF for 14-28 d. A dose-dependent increase in the peripheral white blood cells (WBC) was seen, reaching a plateau after 1 wk of rhG-CSF treatment. The elevation of WBC was due to an increase in the absolute neutrophil count. These results demonstrate that rhG-CSF is a potent granulopoietic growth and differentiation factor in vivo. In cyclophosphamide (CY)-induced myelosuppression, rhG-CSF was able to shorten the time period of WBC recovery in two treated monkeys to 1 wk, as compared to more than 4 wk for the control monkey. Its ability to significantly shorten the period of chemotherapy-induced bone marrow hypoplasia may allow clinicians to increase the frequency or dosage of chemotherapeutic agents. In addition, the increase in absolute numbers of functionally active neutrophils may have a profound effect in the rate and severity of neutropenia-related sepsis. Furthermore, the activities reported here indicate a potential role for rhG-CSF in the treatment of patients with myelodysplastic syndrome, congenital agranulocytosis, radiation-induced myelosuppression, and bone marrow transplantation.
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
April 1993,
The Journal of veterinary medical science,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
September 1991,
Experimental hematology,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
January 1991,
Blood cells,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
January 1991,
Acta haematologica,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
April 1986,
Science (New York, N.Y.),
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
December 1991,
International journal of hematology,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
October 1988,
Blood,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
September 1989,
Experimental hematology,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
March 1998,
British journal of cancer,
K Welte, and
M A Bonilla, and
A P Gillio, and
T C Boone, and
G K Potter, and
J L Gabrilove, and
M A Moore, and
R J O'Reilly, and
L M Souza
June 1995,
Recenti progressi in medicina,
